Latest BOONE CAPITAL MANAGEMENT LLC Stock Portfolio
BOONE CAPITAL MANAGEMENT LLC Performance:
2025 Q4: 9.4%YTD: 19.04%2024: 5.75%
Performance for 2025 Q4 is 9.4%, and YTD is 19.04%, and 2024 is 5.75%.
About BOONE CAPITAL MANAGEMENT LLC and 13F Hedge Fund Stock Holdings
BOONE CAPITAL MANAGEMENT LLC is a hedge fund based in Atlanta, GA. On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, BOONE CAPITAL MANAGEMENT LLC reported an equity portfolio of $318.6 Millions as of 31 Dec, 2025.
The top stock holdings of BOONE CAPITAL MANAGEMENT LLC are MDT, MIRM, IONS. The fund has invested 12.9% of it's portfolio in MEDTRONIC PLC and 10.4% of portfolio in MIRUM PHARMACEUTICALS INC.
The fund managers got completely rid off ICON PLC (ICLR), COGENT BIOSCIENCES INC (COGT) and UNIQURE NV (QURE) stocks. They significantly reduced their stock positions in BRIDGEBIO PHARMA INC (BBIO), RAPT THERAPEUTICS INC (RAPT) and KODIAK SCIENCES INC (KOD). BOONE CAPITAL MANAGEMENT LLC opened new stock positions in ASTRAZENECA PLC (AZN), HEALTHEQUITY INC (HQY) and TYRA BIOSCIENCES INC (TYRA). The fund showed a lot of confidence in some stocks as they added substantially to LIVANOVA PLC (LIVN), BIOMARIN PHARMACEUTICAL INC (BMRN) and THE CIGNA GROUP (CI).
The top stock holdings of BOONE CAPITAL MANAGEMENT LLC are MDT, MIRM, IONS. The fund has invested 12.9% of it's portfolio in MEDTRONIC PLC and 10.4% of portfolio in MIRUM PHARMACEUTICALS INC.
The fund managers got completely rid off ICON PLC (ICLR), COGENT BIOSCIENCES INC (COGT) and UNIQURE NV (QURE) stocks. They significantly reduced their stock positions in BRIDGEBIO PHARMA INC (BBIO), RAPT THERAPEUTICS INC (RAPT) and KODIAK SCIENCES INC (KOD). BOONE CAPITAL MANAGEMENT LLC opened new stock positions in ASTRAZENECA PLC (AZN), HEALTHEQUITY INC (HQY) and TYRA BIOSCIENCES INC (TYRA). The fund showed a lot of confidence in some stocks as they added substantially to LIVANOVA PLC (LIVN), BIOMARIN PHARMACEUTICAL INC (BMRN) and THE CIGNA GROUP (CI).
BOONE CAPITAL MANAGEMENT LLC Annual Return Estimates Vs S&P 500
Our best estimate is that BOONE CAPITAL MANAGEMENT LLC made a return of 9.4% in the last quarter. In trailing 12 months, it's portfolio return was 19.04%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| astrazeneca plc | 20,243,100 |
| healthequity inc | 19,499,700 |
| tyra biosciences inc | 10,476,100 |
| wave life sciences ltd | 5,986,450 |
New stocks bought by BOONE CAPITAL MANAGEMENT LLC
Additions
| Ticker | % Inc. |
|---|---|
| livanova plc | 72.03 |
| biomarin pharmaceutical inc | 25.36 |
| the cigna group | 16.25 |
| unitedhealth group inc | 6.28 |
Additions to existing portfolio by BOONE CAPITAL MANAGEMENT LLC
Reductions
| Ticker | % Reduced |
|---|---|
| bridgebio pharma inc | -59.82 |
| rapt therapeutics inc | -39.87 |
| kodiak sciences inc | -29.62 |
| mirum pharmaceuticals inc | -21.37 |
| neurocrine biosciences inc | -8.77 |
BOONE CAPITAL MANAGEMENT LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| cogent biosciences inc | -13,570,800 |
| abeona therapeutics inc | -2,655,070 |
| clearpoint neuro inc | -6,186,440 |
| uniqure nv | -8,598,890 |
| icon plc | -16,770,600 |
BOONE CAPITAL MANAGEMENT LLC got rid off the above stocks
Sector Distribution
BOONE CAPITAL MANAGEMENT LLC has about 93.6% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 93.6 |
| Others | 6.4 |
Market Cap. Distribution
BOONE CAPITAL MANAGEMENT LLC has about 56.9% of it's portfolio invested in the large-cap and mega-cap stocks.
- LARGE-CAP
- MID-CAP
- SMALL-CAP
- MEGA-CAP
- UNALLOCATED
| Category | % |
|---|---|
| LARGE-CAP | 50.5 |
| MID-CAP | 24 |
| SMALL-CAP | 12.7 |
| MEGA-CAP | 6.4 |
| UNALLOCATED | 6.4 |
Stocks belong to which Index?
About 68.9% of the stocks held by BOONE CAPITAL MANAGEMENT LLC either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
- S&P 500
| Index | % |
|---|---|
| RUSSELL 2000 | 41.2 |
| Others | 31.2 |
| S&P 500 | 27.7 |
BOONE CAPITAL MANAGEMENT LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of BOONE CAPITAL MANAGEMENT LLC
BOONE CAPITAL MANAGEMENT LLC has 15 stocks in it's portfolio. About 81% of the portfolio is in top 10 stocks. CI proved to be the most loss making stock for the portfolio. BBIO was the most profitable stock for BOONE CAPITAL MANAGEMENT LLC last quarter.
Last Reported on: 17 Feb, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABEO | abeona therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AZN | astrazeneca plc | 6.35 | 220,201 | 20,243,100 | new | |||
| BBIO | bridgebio pharma inc | 4.44 | 184,963 | 14,147,800 | reduced | -59.82 | ||
| BMRN | biomarin pharmaceutical inc | 7.68 | 411,880 | 24,478,000 | added | 25.36 | ||
| CI | the cigna group | 8.33 | 96,453 | 26,546,800 | added | 16.25 | ||
| CLPT | clearpoint neuro inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| COGT | cogent biosciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| HQY | healthequity inc | 6.12 | 212,856 | 19,499,700 | new | |||
| ICLR | icon plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| IONS | ionis pharmaceuticals inc | 10.38 | 417,833 | 33,054,800 | unchanged | 0.00 | ||
| KOD | kodiak sciences inc | 4.42 | 503,830 | 14,087,100 | reduced | -29.62 | ||
| LIVN | livanova plc | 5.58 | 288,895 | 17,775,700 | added | 72.03 | ||
| MDT | medtronic plc | 12.93 | 428,789 | 41,189,500 | unchanged | 0.00 | ||
| MIRM | mirum pharmaceuticals inc | 10.44 | 421,236 | 33,273,400 | reduced | -21.37 | ||
| NBIX | neurocrine biosciences inc | 6.76 | 151,815 | 21,531,900 | reduced | -8.77 | ||
| QURE | uniqure nv | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| RAPT | rapt therapeutics inc | 5.00 | 470,456 | 15,934,300 | reduced | -39.87 | ||
| TYRA | tyra biosciences inc | 3.29 | 398,482 | 10,476,100 | new | |||
| UNH | unitedhealth group inc | 6.40 | 61,762 | 20,388,300 | added | 6.28 | ||
| WVE | wave life sciences ltd | 1.88 | 352,144 | 5,986,450 | new | |||